Advances in Clinical and Experimental Medicine

19/01/2026

Our answer to Blue Monday? 🙁 Instead of light-hearted distractions, we can delve into a serious problem presented in an interesting 🧐 visually appealing ✨and scientifically insightful way 🧑‍🔬

The publication “Recent advances in the study of perinatal mental health: Epidemiology, psychopathology and intervention,” selected as Editor-in-Chief's Top Pick 2025, clearly demonstrates that a mother’s mental state is an equally important dimension of maternal health.

👉Read it here: https://wroclaw-medical-university.shorthandstories.com/mental-health-during-pregnancy-and-the-postpartum-period/

18/01/2026

📢¡Únete al movimiento para avanzar en la salud mental y el bienestar!📢

Advances in Clinical and Experimental Medicine te invita a enviar tu investigación y artículos de vanguardia en el campo de la salud mental y el bienestar. Buscamos contribuciones innovadoras que amplíen los límites de la comprensión, el tratamiento y la promoción del bienestar mental.

Editores a cargo

Prof. Dr. Raúl Juárez-Vela (Grupo de Investigación en Cuidados (GRUPAC), Facultad de Ciencias de la Salud, Universidad de La Rioja, Logroño, España; ORCID 0000-0003-3597-2048) [email protected]

Los temas de interés incluyen, pero no se limitan a:

- Intervenciones terapéuticas innovadoras
- Estrategias para la prevención y promoción del bienestar mental
- Impacto de la salud mental en la calidad de vida
- Nuevos enfoques en el tratamiento de trastornos mentales
- Estudios sobre la relación entre la salud mental y las enfermedades físicas

¿Por qué publicar con nosotros?

- Visibilidad global: Alcanza una amplia audiencia internacional con tu trabajo.
- Revisión rigurosa: Benefíciate de nuestro proceso de revisión por pares de alta calidad.
- Impacto académico: Haz una contribución significativa a un campo vital y dinámico.

Proceso de envío

Como primer paso, solicitamos el envío de una Expresión de Interés con un resumen de artículos originales que aborden los temas mencionados al Editor de Sección de Adv Clin Exp Med: [email protected]

El Editor de Sección, junto con el Editor en Jefe, revisará todas las presentaciones y seleccionará aquellas que serán invitadas a enviar un artículo completo. El proceso de envío seguirá el proceso en línea regular de Adv Clin Exp Med. Todos los manuscritos serán enviados a al menos dos revisores independientes.

Fechas y tarifas

- Envío de la Expresión de Interés hasta el 31 de diciembre de 2025 a [email protected]
- Invitación para enviar un artículo completo antes del 31 de enero de 2026;
- Envío del artículo completo antes del 31 de marzo de 2026.

Si se acepta, los autores deberán pagar una tarifa (https://advances.umw.edu.pl/en/article-processing-charges/) para cubrir los costos de publicación;

Para autores seleccionados (expertos destacados), es posible reducir o incluso cancelar la tarifa de publicación.

Envía tu manuscrito hoy y únete a la conversación global sobre el mejoramiento de la salud mental y el bienestar. Para más detalles sobre el proceso de envío, visita nuestro sitio web.

¡Esperamos con ansias tus valiosas contribuciones!

18/01/2026

📢New call for submissions📢

📢Join the Movement to Advance Mental Health and Wellbeing!📢

Advances in Clinical and Experimental Medicine invites you to submit your cutting-edge research and articles in the field of Mental Health and Well-being. We are seeking groundbreaking contributions that push the boundaries of understanding, treating, and promoting mental wellbeing.

Handling Editors

Prof. Raúl Juárez-Vela (Group of Research in Care (GRUPAC), Faculty of Health Sciences, University of La Rioja, Logroño, Spain; ORCID 0000-0003-3597-2048) [email protected]

Topics of interest include, but are not limited to:

Innovative therapeutic interventions
Strategies for prevention and promotion of mental wellbeing
Impact of mental health on quality of life
New approaches in the treatment of mental disorders
Studies on the relationship between mental health and physical diseases

Why publish with us?

Global Visibility: Reach a wide international audience with your work
Rigorous Review: Benefit from our high-quality peer review process
Academic Impact: Make a significant contribution to a vital and dynamic field

Submission process

As a first step, we ask for submissions of an Expression of Interest with an Abstract of original papers outlining the themes above to Adv Clin Exp Med Section Editor: [email protected]

The Section Editor, jointly with the Editor-in-Chief, will review all submissions and select those who will be invited to submit a full paper. The submission process will then follow the regular Adv Clin Exp Med. online process. All manuscripts will be sent to at least two independent reviewers.

Dates and fees

Submission of Expression of Interest until December 31, 2025, to [email protected]
Invitation to submit a full paper by January 31, 2026;
Submission of full paper by March 31, 2026.
If accepted, Authors will be required to pay a fee (https://advances.umw.edu.pl/en/article-processing-charges/) to cover publication costs;

For selected Authors (outstanding experts), it is possible to reduce or even cancel the publication fee.

Submit your manuscript today and join the global conversation on enhancing mental health and well-being. For more details on the submission process, visit our website.

We eagerly anticipate your valuable contributions!

17/01/2026

📢Call for submissions of an Expression of Interest for an Adv Clin Exp Med Special Collection on Advances in Cardiovascular Care 📢

This Special Issue of the Advances in Clinical and Experimental Medicine will provide focused, comprehensive coverage of important clinical topics in cardiology. The issue will address selected clinical problems or conditions, including their pathophysiology, invasive and noninvasive diagnosis, drug therapy, surgical management, and rehabilitation.

This Special Issue aims to provide researchers with an opportunity to publish original research, meta-analyses and review articles related to recent advances in the cardiovascular field, with a particular focus on holistic and personalized management of patients with CVD.

Topic and format
Advances in Clinical and Experimental Medicine is therefore seeking original papers for a Special Collection focused on cardiovascular care.

MORE INFORMATION:

https://advances.umw.edu.pl/en/call-for-submissions-of-an-expression-of-interest-for-an-adv-clin-exp-med-special-collection-on-advances-in-cardiovascular-care


Izabella Uchmanowicz
Dr hab. Michał Czapla
Uniwersytet Medyczny im. Piastów Śląskich we Wrocławiu

16/01/2026

📚Publish in Advances in Clinical and Experimental Medicine! 📚

💪 WHY?
– We have a broad scope and publish papers from all fields of medicine and related sciences;
– Our Impact Factor is 1.9 and steadily rising [see below];
– Our Scopus CiteScore is 4.3 and also steadily rising;
– We publish papers ahead of print [with active DOI] as soon as they are ready – no unnecessary waiting;
– We are indexed in all important databases;
– We offer professional linguistic editing and DTP;
– If you become our reviewer, article processing charge can be waivered.

🔎 HOW?
Create an account here:
https://www.editorialsystem.com/acem/preRegister/?email=
Check our instructions for authors here:
https://advances.umw.edu.pl/en/instructions-for-authors/
and submit your paper!

🔥 EDITORIALS
We invite experts to submit an editorial to our journal. Editorials published in our journal are meant to promote current and crucial directions of research in experimental and clinical medicine. Such article is published free of charge.
https://ojs.umw.edu.pl/files/acem/Flyer_ACEM_popr_2025-editorial%20(9)-1.pdf

🔥 CALLS FOR SUBMISSION
Current calls for submissions in ACEM are listed below. Please share them with the members of your professional networks.
https://advances.umw.edu.pl/en/calls-for-submissions/

16/01/2026

🚀 Ahead of print 🚀

Cisplatin-induced WWP1-eccDNA expression contributes to ovarian cancer resistance

Highlights

➡️WWP1-eccDNA drives ovarian cancer (OC) drug resistance: Elevated extrachromosomal circular DNA of the WWP1 gene promotes chemotherapy evasion in ovarian tumors.
➡️ddPCR outperforms qPCR for eccDNA quantification: Digital droplet PCR delivers higher sensitivity and accuracy when measuring low-abundance WWP1-eccDNA.
➡️Cisplatin treatment upregulates WWP1-eccDNA levels: Platinum-based chemotherapy significantly increases WWP1-eccDNA in resistant OC cells.
➡️Hydroxyurea reduces WWP1-eccDNA abundance: DNA synthesis inhibition with hydroxyurea lowers eccDNA copy number, suggesting a strategy to counteract resistance.
➡️WWP1-eccDNA as a therapeutic target: Targeting eccDNA biogenesis or stability offers a novel approach to reverse OC drug resistance.

https://advances.umw.edu.pl/en/ahead-of-print/204077/

15/01/2026

🏆TopPick 2025🏆

Our Editors-in-Chief, Prof. Donata Kurpas and Prof. Robert Śmigiel, chose two papers published in 2025 as worth your particular attention. We prepared podcasts to disseminate these articles also among lay public since they include information important not only to specialists.

📣Please help us promote these podcasts and publications with all means available to you – including social media, professional communities and newsletters📣

TOP PICK 2025 🏆 Redaktorzy naczelni naszych czasopism naukowych – Advances in Clinical and Experimental Medicine, Dental and Medical Problems oraz Polimery w Medycynie / Polymers in Medicine – wybrali najlepsze artykuły 2025 roku. Poznajcie publikacje, które wskazują kierunek rozwoju współczesnej medycyny i nauk biomedycznych:

🧠 Zdrowie psychiczne w okresie ciąży i po porodzie
Artykuł poświęcony zaburzeniom psychicznym w okresie okołoporodowym pokazuje skalę zjawiska oraz jego znaczenie dla zdrowia matki i rozwoju dziecka.
🔎 https://tiny.pl/479xq-cs3

❤️ Niewydolność serca a funkcjonowanie poznawcze i emocjonalne
Publikacja analizuje zmiany pamięci, koncentracji i nastroju u pacjentów z niewydolnością serca oraz ich wpływ na samoopiekę i przebieg leczenia.
🔎 https://tiny.pl/zdn96qbpt

🦷 Lasery w zapobieganiu i leczeniu próchnicy
Artykuł prezentuje międzynarodowy konsensus ekspertów dotyczący zastosowania technologii laserowych w profilaktyce i minimalnie inwazyjnym leczeniu próchnicy.
🔎 https://tiny.pl/j5v6rvqh4

🦷 Cyfrowa ocena ryzyka chorób przyzębia (algorytm GF-PeDRA©)
Publikacja przedstawia innowacyjne narzędzie do całościowej oceny ryzyka, diagnozy i rokowania w chorobach przyzębia i wokół implantów.
🔎 https://tiny.pl/kq6g5rtm0

🧪 Propolis w nowoczesnych materiałach stomatologicznych
Autorzy opisują możliwość wykorzystania naturalnych substancji, takich jak propolis, do modyfikacji materiałów protetycznych.
🔎 https://tiny.pl/cq04fygk5

💡 Terapia fotodynamiczna i nośniki polimerowe w medycynie
Artykuł omawia rozwój terapii fotodynamicznej oraz rolę nośników polimerowych w zwiększaniu jej selektywności i bezpieczeństwa.
🔎 https://tiny.pl/yjxr91pz3

15/01/2026

🚀Ahead of print🚀

🚀IGF2BP2-mediated m6A modifies SLC7A11 to regulate proliferation and ferroptosis in non-small cell lung cancer cells🚀

Discover groundbreaking insights into how IGF2BP2 drives non-small cell lung cancer (NSCLC) progression. By stabilizing SLC7A11 mRNA through m6A modification, IGF2BP2 enhances cell proliferation while promoting ferroptosis resistance. Overexpression of IGF2BP2 leads to elevated SLC7A11 levels, reducing oxidative stress markers and ferroptosis indicators. This stabilization of SLC7A11 mRNA supports redox homeostasis and metabolic reprogramming in cancer cells, further underscoring IGF2BP2's critical role.

Conversely, IGF2BP2 knockdown significantly increases ferroptosis and decreases cell viability, highlighting its potential as a therapeutic target. Targeting the IGF2BP2-SLC7A11 axis offers promising strategies to improve clinical outcomes in NSCLC treatment.

https://advances.umw.edu.pl/en/ahead-of-print/200588/

14/01/2026

🚀Ahead of print 🚀

Outcomes of the toe PIP joint transfer for IIIB hypoplastic thumb: Is it justified when pollicization is denied?

Highlights

➡️Long-term results after stabilization of hypoplastic thumb type III B using foot proximal interphalangeal (PIP) joint transfer delivers durable thumb stability and enhanced grip function.
➡️PIP joint transfer from the foot serves as a reliable reconstructive alternative when pollicization is not accepted by parents.
➡️Significant improvements in operated-hand grip strength and stability were documented in extended follow-up assessments.
➡️Outcomes comparable to established thumb reconstruction techniques validate the efficacy of this non-pollicization approach.
➡️Patient-centered surgical choice: This method respects parental preference by providing functional thumb reconstruction without pollicization.

https://advances.umw.edu.pl/en/ahead-of-print/206081/

14/01/2026

🚀Ahead of print 🚀

The correlation between nailfold capillaroscopic findings and adaptive optics imaging of retinal microvasculature in patients with systemic sclerosis

Highlights

➡️Adaptive optics unveils retinal microvascular changes in systemic sclerosis (SSc): First study to apply high-resolution AO imaging in scleroderma patients.
➡️Concordance between nailfold capillaroscopy and adaptive optics metrics: Combined modalities enhance accuracy in detecting SSc microangiopathy.
➡️Thinner retinal vessel walls in SSc vs controls: Quantitative AO analysis shows significant retinal wall thinning.
➡️Adaptive optics as a novel diagnostic tool for SSc microvascular injury: Promises noninvasive, early detection and monitoring of microvascular changes in scleroderma.

https://advances.umw.edu.pl/en/ahead-of-print/204078/

13/01/2026

📢Meet the author of our latest editorial!📢

Prof. Sabine Bährer-Kohler

✔️ READ THE EDITORIAL

Access to services. Mental health in catastrophes and emergencies: Aspects

https://advances.umw.edu.pl/en/article/2025/34/12/1995/

✔️SHORT BIO
https://www.iassw-aiets.org/personnel/sabine-bahrerkohler/

✔️MINI-INTERVIEW
https://ojs.umw.edu.pl/files/acem/FINAL.pdf

12/01/2026

🚀Ahead of print🚀

Clearing the path: Hypertonic saline’s impact on intracranial pressure in traumatic brain injury. A systematic review and meta-analysis

Highlights

➡️Traumatic brain injury (TBI) occurs when the brain is harmed by a quick, external and violent impact, such as in sports or car accidents. Worldwide, it is a leading cause of mortality and lasting disability in people.
➡️Increased intracranial pressure (ICP) has a major negative impact on neurological outcomes and mortality rates in individuals with TBI.
➡️Hypertonic saline (HTS), a hyperosmolar therapy, manages increased ICP in TBI patients. However, there is still some dispute over the efficacy of HTS in TBI treatment.
➡️The present analysis shows that HTS outperforms other hyperosmolar agents like mannitol in reducing ICP, improving neurological outcomes, reducing mortality and shortening hospital or ICU stays in acute TBI patients.

https://advances.umw.edu.pl/en/ahead-of-print/197437/